CryoCor’s Cryoablation System For Atrial Flutter Is Non-Approvable, FDA Says

CryoCor is planning to amend its PMA after receiving a non-approvable letter from FDA for its CryoCor cardiac cryoablation system for the treatment of atrial flutter, according to CEO Greg Ayers, MD

More from Archive

More from Medtech Insight